Potential of boron neutron capture therapy (BNCT) for myxofibrosarcoma
Takuya Fujimoto1, Tooru Andoh2, Tamotsu Sudo3
1Department of Orthopaedic Surgery, Hyogo Cancer Center, Akashi, 673-8558, Japan.
Abstract:
Myxofibrosarcoma, a rare malignant tumor, predominantly affects the extremities of the elderly. Because of its invasive nature amputation is sometimes required, resulting in serious deterioration of quality of life. Therefore, cell lines established from amputated surgical specimens of myxofibrosarcoma in the upper limbs of elderly patients were used to create a myxofibrosarcoma-bearing animal model and to investigate the therapeutic effect of BNCT thereon. The results demonstrated selective destruction of tumor cells, suggesting the anti-tumor efficacy of BNCT on myxofibrosarcoma.
Keywords:
Boron neutron capture therapy (BNCT)Cell lineMyxofibrosarcomap-borono-(L)-phenylalanine ((L)-BPA)

